Quoin Pharmaceuticals QNRX Ratios (2017-2026)

NASDAQ QNRX
$6.97 -0.18 (-2.52%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Quoin Pharmaceuticals Quarterly Ratios

Periods 27 quarters
Latest Jun 2026

Quoin Pharmaceuticals ratios data for the quarter ended Jun 2026. These financial ratios cover 27 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2017 Jun2018 Dec2018 Jun2019 Jun2020 Dec2020 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Efficiency
Assets AverageAssets Avg.
0.01B0.02B0.02B0.02B0.02B0.01B0.01B0.02B0.01B0.01B0.01B0.01B0.01B0.01B0.02B0.01B
Invested CapitalInvested Cap.
0.01B0.00B0.01B0.02B0.01B
Leverage & Solvency
Debt Ratio
0.501.020.260.530.22
Valuation
Price to EarningsP/E
-0.00B-0.00B-2.77-24.06-2.48-2.76
Price to BookP/B
-0.00B0.00B-214.09-1.700.936.504.670.760.641.000.260.460.530.390.030.07-0.120.040.070.12
Enterprise Value
1,262.96B504.78B0.16B0.00B0.00B0.05B0.05B0.00B0.00B0.00B0.00B0.00B-0.00B-0.01B-0.00B-0.00B-0.01B-0.02B-0.01B-0.01B
Market Capitalization
1,262.96B504.79B0.16B0.01B0.01B0.05B0.05B0.01B0.00B0.01B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Price to FCFP/FCF
-0.00B-0.00B-74.59-2.51-3.73-24.79-29.18-4.39-3.62-1.75-1.63-1.70-1.33-1.59-0.06-0.05-0.06-0.10-0.13-0.15
EV to FCF
-0.00B-0.00B-74.59-1.26-1.45-23.32-27.23-1.34-1.20-1.01-0.35-0.280.104.691.410.412.373.622.763.30
EV to CFO
-0.00B-0.00B-74.59-1.26-1.45-23.32-27.23-1.34-1.20-1.01-0.35-0.280.104.691.410.412.373.622.763.30